Importantly, a recent study by Shah and colleagues [11] has demonstrated that the intra-tumor genetic heterogeneity found in breast cancers may affect even known driver genetic aberrations, such as TP53 and PIK3CA somatic mutations. This evidence concerns the gene TP53 and neoplasm.